Design Pharmaceuticals
Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Their goal is to enable new treatments for patients suffering from diseases for which there are no satisfactory therapies. The company leverages its multiplex GPCR platform for scalable and flexible interrogation of GPCR signaling for drug development, enabling data generation for computational and experimental drug design. They collaborate with R&D teams on discovery projects and joint research programs to develop breakthrough therapeutics for GPCR drug targets by screening large complex libraries for hit candidates based on drug function.
Design Pharmaceuticals
Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Their goal is to enable new treatments for patients suffering from diseases for which there are no satisfactory therapies. The company leverages its multiplex GPCR platform for scalable and flexible interrogation of GPCR signaling for drug development, enabling data generation for computational and experimental drug design. They collaborate with R&D teams on discovery projects and joint research programs to develop breakthrough therapeutics for GPCR drug targets by screening large complex libraries for hit candidates based on drug function.